Teladoc Health, Inc. TDOC NYSE

Teladoc Health, Inc. (TDOC) reported total assets of $3.1B and total liabilities of $1.72B for fiscal year 2025, resulting in total equity of $1.39B.

The company held $781.08M in cash and short-term investments. Total debt stood at $1.04B, with net debt of $259.08M. The Debt-to-Equity (D/E) ratio was 0.75 (moderate).

Current ratio is 2.69, indicating strong short-term liquidity. Interest coverage is -13.3x (weak).

Criteria supported by this page:

• HEALTH (50/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (64/100) — Total assets $3.1B and equity $1.39B support the company's competitive scale
• VALUE (100/100) — Debt-to-Equity 0.75 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 44/100 with 1/7 criteria passed.

GEHC

GE HealthCare Technologies Inc.

$74.67

+1.14%

VEEV

Veeva Systems Inc.

$159.09

+0.40%

DOCS

Doximity, Inc.

$22.25

-1.81%

TXG

10x Genomics, Inc.

$24.80

+5.17%

IMNM

Immunome, Inc.

$22.90

+1.24%

PHVS

Pharvaris N.V.

$28.68

+2.87%

OMCL

Omnicell, Inc.

$36.33

+3.77%

PGNY

Progyny, Inc.

$17.17

+1.12%